Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Liesel Wett - the new CEO for the PSA
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
In a shrewd management decision, the Board of the Pharmaceutical Society of Australia has announced the appointment of Liesel Wett as the organisation’s new Chief Executive Officer.
Ms Wett, who is currently Deputy Chief Executive Officer and Chief Operating Officer of the Australian General Practice Network, is expected to take up her appointment on 1 October 2010.
Given that the PSA will need to develop closer and stronger ties with GP organisations, this appointment may well prove to be critical for the future professional development of pharmacists.
Pharmacists will be enabled to get inside and understand GP thinking, guided by Liesel Wett.
National President of the PSA, Warwick Plunkett, said Ms Wett would bring to the role a wealth of experience in the health field, not only through her career in health organisations but also through her formal qualifications.
“As well as her executive roles at AGPN, Liesel has held senior executive roles at other health organisations and holds an MBA and relevant other qualifications in health-related areas including a Masters in Public Health,” Mr Plunkett said.
“She has been at AGPN since 2003 during which time she also assumed the role of Acting CEO for some 12 months.”
Mr Plunkett said in her roles Ms Wett had developed strong and ongoing relationships with Government and public sector stakeholders which, combined with her experience in setting and driving strategic direction of a peak body, would help take PSA forward during very challenging times for the health sector.
“Her strong experience in liaising and negotiating with the Minister’s office and staff, senior Department of Health staff as well as staff across the health network, will help to ensure PSA’s voice is heard and that the interests of pharmacy are taken into account,” Mr Plunkett said.
“Her background and experience with the AGPN offers the opportunity to build better bridges with the medical profession which will be essential for implementing much of the desired future extended professional role for pharmacists
“Liesel is also very experienced in working with and on Boards, serves on the Godwin Homes Board in Canberra and is involved in making investment portfolio decisions.
“At AGPN she has served as Company Secretary and completed Australian Institute of Company Director qualifications.
“Her appointment is a great asset for the PSA and for the pharmacy profession.”
Return to homeResearch Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment